Cable company employees to learn the new "safety production law"
Release time:
2021-08-23
News from our newspaper # February 6 , the cable company used the morning meeting platform to organize all employees to learn the contents of the new "Safety Production Law" in order to understand and master the difference between the old and new "Safety Production Law", improve their own safety awareness, and achieve safe and standardized production. This study will last for one month.
The newly revised "the People's Republic of China Safety Production Law" will be formally implemented on 2021 9# November 1 . To this end, the cable company specially set 8 as the new "safety production law" learning month, so that all employees can learn the contents of the new "safety production law" in advance. Employees take the stage to share and learn a little every day, which is convenient for employees to absorb, understand and accept, deeply understand and understand its internal meaning, so that employees can apply what they have learned, better link theory and practice, and then better apply it to practice. In work, improve the learning effect. The new "Safety Production Law" involves many amendments. According to the actual situation of the cable company, the employees responsible for sharing at the morning meeting strengthen safety production management for production and business units, improve risk prevention and resolution mechanisms, and improve the level of safety production; carry out hazard identification and assessment; perform safety production management responsibilities; implement post safety production responsibilities; after the occurrence of production safety accidents and other disposal and cable companies, employees are more relevant to the content to focus on learning. This training mainly compares the differences between the old and new "Safety Production Law", puts forward its own ideas, and makes the content easy to understand, so as to deepen the understanding of employees and further standardize the operation. After learning, training and sharing of experience, employees not only learned the "Safety Production Law" and increased their knowledge, but also realized the importance of safety to enterprises and individuals, and benefited a lot. Wang Debo, assistant to the general manager of
Cable Company, said that according to factors such as the increase in equipment, the increase in production capacity, the increase in demand for risk prevention and control, and the increasing number of new safety risks in the cable company, the safety literacy of employees needs to be further improved. Each employee needs to be clear about the importance and necessity of safety education and training; the person in charge of the enterprise, the safety production management personnel and the front-line key post personnel need to understand the knowledge of safety production and improve the safety management ability, so it is very necessary to organize the study of the new "safety production law. At the same time, this is also an important work in the three-year action plan for on-site governance of cable companies to improve the level of enterprise safety production, improve safety production conditions, strengthen safety production standardization, and information construction. (Huang Yuan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page